دورية أكاديمية

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel

التفاصيل البيبلوغرافية
العنوان: Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
المؤلفون: Sarantopoulos, John, Mita, Alain C., Wade, James L., Morris, John C., Rixe, Olivier, Mita, Monica M., Dedieu, Jean-François, Wack, Claudine, Kassalow, Laurent, Craig Lockhart, A.
المصدر: Cancer Chemotherapy and Pharmacology ; volume 74, issue 6, page 1113-1124 ; ISSN 0344-5704 1432-0843
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2014
مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Pharmacology, Toxicology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s00280-014-2572-z
DOI: 10.1007/s00280-014-2572-z.pdf
DOI: 10.1007/s00280-014-2572-z/fulltext.html
الإتاحة: https://doi.org/10.1007/s00280-014-2572-zTest
حقوق: http://www.springer.com/tdmTest
رقم الانضمام: edsbas.E8F7E552
قاعدة البيانات: BASE